Table of Content

1 Human Gene Therapy Market Overview
1.1 Human Gene Therapy Product Overview
1.2 Human Gene Therapy Market Segment by Type
1.2.1 Non-viral Vectors
1.2.2 Viral Vectors
1.3 Global Human Gene Therapy Market Size by Type
1.3.1 Global Human Gene Therapy Market Size Overview by Type (2018-2029)
1.3.2 Global Human Gene Therapy Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Gene Therapy Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Gene Therapy Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Gene Therapy Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Gene Therapy Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Gene Therapy Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Gene Therapy Sales Breakdown by Type (2018-2024)
2 Global Human Gene Therapy Market Competition by Company
2.1 Global Top Players by Human Gene Therapy Sales (2018-2024)
2.2 Global Top Players by Human Gene Therapy Revenue (2018-2024)
2.3 Global Top Players by Human Gene Therapy Price (2018-2024)
2.4 Global Top Manufacturers Human Gene Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Gene Therapy Market Competitive Situation and Trends
2.5.1 Human Gene Therapy Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Gene Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into Human Gene Therapy Market
2.8 Key Manufacturers Human Gene Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Gene Therapy Status and Outlook by Region
3.1 Global Human Gene Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Gene Therapy Historic Market Size by Region
3.2.1 Global Human Gene Therapy Sales in Volume by Region (2018-2024)
3.2.2 Global Human Gene Therapy Sales in Value by Region (2018-2024)
3.2.3 Global Human Gene Therapy Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Gene Therapy Forecasted Market Size by Region
3.3.1 Global Human Gene Therapy Sales in Volume by Region (2024-2029)
3.3.2 Global Human Gene Therapy Sales in Value by Region (2024-2029)
3.3.3 Global Human Gene Therapy Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Gene Therapy by Application
4.1 Human Gene Therapy Market Segment by Application
4.1.1 Neurological Diseases
4.1.2 Cancer
4.1.3 DMD (Duchenne Muscular Dystrophy)
4.1.4 Hepatological Diseases
4.1.5 Others
4.2 Global Human Gene Therapy Market Size by Application
4.2.1 Global Human Gene Therapy Market Size Overview by Application (2018-2029)
4.2.2 Global Human Gene Therapy Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Gene Therapy Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Gene Therapy Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Gene Therapy Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Gene Therapy Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Gene Therapy Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Gene Therapy Sales Breakdown by Application (2018-2024)
5 North America Human Gene Therapy by Country
5.1 North America Human Gene Therapy Historic Market Size by Country
5.1.1 North America Human Gene Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Gene Therapy Sales in Volume by Country (2018-2024)
5.1.3 North America Human Gene Therapy Sales in Value by Country (2018-2024)
5.2 North America Human Gene Therapy Forecasted Market Size by Country
5.2.1 North America Human Gene Therapy Sales in Volume by Country (2024-2029)
5.2.2 North America Human Gene Therapy Sales in Value by Country (2024-2029)
6 Europe Human Gene Therapy by Country
6.1 Europe Human Gene Therapy Historic Market Size by Country
6.1.1 Europe Human Gene Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Gene Therapy Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Gene Therapy Sales in Value by Country (2018-2024)
6.2 Europe Human Gene Therapy Forecasted Market Size by Country
6.2.1 Europe Human Gene Therapy Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Gene Therapy Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Gene Therapy by Region
7.1 Asia-Pacific Human Gene Therapy Historic Market Size by Region
7.1.1 Asia-Pacific Human Gene Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Gene Therapy Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Gene Therapy Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Gene Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Gene Therapy Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Gene Therapy Sales in Value by Region (2024-2029)
8 Latin America Human Gene Therapy by Country
8.1 Latin America Human Gene Therapy Historic Market Size by Country
8.1.1 Latin America Human Gene Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Gene Therapy Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Gene Therapy Sales in Value by Country (2018-2024)
8.2 Latin America Human Gene Therapy Forecasted Market Size by Country
8.2.1 Latin America Human Gene Therapy Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Gene Therapy Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Gene Therapy by Country
9.1 Middle East and Africa Human Gene Therapy Historic Market Size by Country
9.1.1 Middle East and Africa Human Gene Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Gene Therapy Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Gene Therapy Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Gene Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Gene Therapy Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Gene Therapy Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Biogen
10.1.1 Biogen Company Information
10.1.2 Biogen Introduction and Business Overview
10.1.3 Biogen Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Biogen Human Gene Therapy Products Offered
10.1.5 Biogen Recent Development
10.2 Sarepta Therapeutics
10.2.1 Sarepta Therapeutics Company Information
10.2.2 Sarepta Therapeutics Introduction and Business Overview
10.2.3 Sarepta Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sarepta Therapeutics Human Gene Therapy Products Offered
10.2.5 Sarepta Therapeutics Recent Development
10.3 Gilead Sciences
10.3.1 Gilead Sciences Company Information
10.3.2 Gilead Sciences Introduction and Business Overview
10.3.3 Gilead Sciences Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Gilead Sciences Human Gene Therapy Products Offered
10.3.5 Gilead Sciences Recent Development
10.4 Amgen
10.4.1 Amgen Company Information
10.4.2 Amgen Introduction and Business Overview
10.4.3 Amgen Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amgen Human Gene Therapy Products Offered
10.4.5 Amgen Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novartis Human Gene Therapy Products Offered
10.5.5 Novartis Recent Development
10.6 Orchard Therapeutics
10.6.1 Orchard Therapeutics Company Information
10.6.2 Orchard Therapeutics Introduction and Business Overview
10.6.3 Orchard Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Orchard Therapeutics Human Gene Therapy Products Offered
10.6.5 Orchard Therapeutics Recent Development
10.7 Spark Therapeutics
10.7.1 Spark Therapeutics Company Information
10.7.2 Spark Therapeutics Introduction and Business Overview
10.7.3 Spark Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Spark Therapeutics Human Gene Therapy Products Offered
10.7.5 Spark Therapeutics Recent Development
10.8 Agc Biologics
10.8.1 Agc Biologics Company Information
10.8.2 Agc Biologics Introduction and Business Overview
10.8.3 Agc Biologics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Agc Biologics Human Gene Therapy Products Offered
10.8.5 Agc Biologics Recent Development
10.9 Anges
10.9.1 Anges Company Information
10.9.2 Anges Introduction and Business Overview
10.9.3 Anges Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Anges Human Gene Therapy Products Offered
10.9.5 Anges Recent Development
10.10 Bluebird Bio
10.10.1 Bluebird Bio Company Information
10.10.2 Bluebird Bio Introduction and Business Overview
10.10.3 Bluebird Bio Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bluebird Bio Human Gene Therapy Products Offered
10.10.5 Bluebird Bio Recent Development
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Company Information
10.11.2 Jazz Pharmaceuticals Introduction and Business Overview
10.11.3 Jazz Pharmaceuticals Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Jazz Pharmaceuticals Human Gene Therapy Products Offered
10.11.5 Jazz Pharmaceuticals Recent Development
10.12 Dynavax Technologies
10.12.1 Dynavax Technologies Company Information
10.12.2 Dynavax Technologies Introduction and Business Overview
10.12.3 Dynavax Technologies Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Dynavax Technologies Human Gene Therapy Products Offered
10.12.5 Dynavax Technologies Recent Development
10.13 Human Stem Cells Institute
10.13.1 Human Stem Cells Institute Company Information
10.13.2 Human Stem Cells Institute Introduction and Business Overview
10.13.3 Human Stem Cells Institute Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Human Stem Cells Institute Human Gene Therapy Products Offered
10.13.5 Human Stem Cells Institute Recent Development
10.14 Sibiono Genetech
10.14.1 Sibiono Genetech Company Information
10.14.2 Sibiono Genetech Introduction and Business Overview
10.14.3 Sibiono Genetech Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Sibiono Genetech Human Gene Therapy Products Offered
10.14.5 Sibiono Genetech Recent Development
10.15 Shanghai Sunway Biotech
10.15.1 Shanghai Sunway Biotech Company Information
10.15.2 Shanghai Sunway Biotech Introduction and Business Overview
10.15.3 Shanghai Sunway Biotech Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shanghai Sunway Biotech Human Gene Therapy Products Offered
10.15.5 Shanghai Sunway Biotech Recent Development
10.16 Uniqure N.V.
10.16.1 Uniqure N.V. Company Information
10.16.2 Uniqure N.V. Introduction and Business Overview
10.16.3 Uniqure N.V. Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Uniqure N.V. Human Gene Therapy Products Offered
10.16.5 Uniqure N.V. Recent Development
10.17 Gensight Biologics S.A.
10.17.1 Gensight Biologics S.A. Company Information
10.17.2 Gensight Biologics S.A. Introduction and Business Overview
10.17.3 Gensight Biologics S.A. Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Gensight Biologics S.A. Human Gene Therapy Products Offered
10.17.5 Gensight Biologics S.A. Recent Development
10.18 Celgene Corporation
10.18.1 Celgene Corporation Company Information
10.18.2 Celgene Corporation Introduction and Business Overview
10.18.3 Celgene Corporation Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Celgene Corporation Human Gene Therapy Products Offered
10.18.5 Celgene Corporation Recent Development
10.19 Cellectis
10.19.1 Cellectis Company Information
10.19.2 Cellectis Introduction and Business Overview
10.19.3 Cellectis Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Cellectis Human Gene Therapy Products Offered
10.19.5 Cellectis Recent Development
10.20 Sangamo Therapeutics
10.20.1 Sangamo Therapeutics Company Information
10.20.2 Sangamo Therapeutics Introduction and Business Overview
10.20.3 Sangamo Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Sangamo Therapeutics Human Gene Therapy Products Offered
10.20.5 Sangamo Therapeutics Recent Development
10.21 Mustang Bio
10.21.1 Mustang Bio Company Information
10.21.2 Mustang Bio Introduction and Business Overview
10.21.3 Mustang Bio Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Mustang Bio Human Gene Therapy Products Offered
10.21.5 Mustang Bio Recent Development
10.22 AGTC
10.22.1 AGTC Company Information
10.22.2 AGTC Introduction and Business Overview
10.22.3 AGTC Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.22.4 AGTC Human Gene Therapy Products Offered
10.22.5 AGTC Recent Development
10.23 Poseida Therapeutics
10.23.1 Poseida Therapeutics Company Information
10.23.2 Poseida Therapeutics Introduction and Business Overview
10.23.3 Poseida Therapeutics Human Gene Therapy Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Poseida Therapeutics Human Gene Therapy Products Offered
10.23.5 Poseida Therapeutics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Gene Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Gene Therapy Industrial Chain Analysis
11.4 Human Gene Therapy Market Dynamics
11.4.1 Human Gene Therapy Industry Trends
11.4.2 Human Gene Therapy Market Drivers
11.4.3 Human Gene Therapy Market Challenges
11.4.4 Human Gene Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Gene Therapy Distributors
12.3 Human Gene Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Non-viral Vectors
Table 2. Major Company of Viral Vectors
Table 3. Global Human Gene Therapy Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Human Gene Therapy Sales by Type (2018-2024) & (K Units)
Table 5. Global Human Gene Therapy Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Human Gene Therapy Sales by Type (2018-2024) & (US& Million)
Table 7. Global Human Gene Therapy Market Share in Value by Type (2018-2024)
Table 8. Global Human Gene Therapy Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Human Gene Therapy Sales by Type (2024-2029) & (K Units)
Table 10. Global Human Gene Therapy Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Human Gene Therapy Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Human Gene Therapy Sales Market Share in Value by Type (2024-2029)
Table 13. Global Human Gene Therapy Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Human Gene Therapy Sales by Type (2018-2024) & (K Units)
Table 15. North America Human Gene Therapy Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Human Gene Therapy Sales (K Units) by Type (2018-2024)
Table 17. Europe Human Gene Therapy Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Human Gene Therapy Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Human Gene Therapy Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Human Gene Therapy Sales (K Units) by Type (2018-2024)
Table 21. Latin America Human Gene Therapy Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Human Gene Therapy Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Human Gene Therapy Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Human Gene Therapy Sales by Company (2018-2024) & (K Units)
Table 25. Global Human Gene Therapy Sales Share by Company (2018-2024)
Table 26. Global Human Gene Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Human Gene Therapy Revenue Share by Company (2018-2024)
Table 28. Global Market Human Gene Therapy Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Human Gene Therapy Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Human Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2022)
Table 32. Date of Key Manufacturers Enter into Human Gene Therapy Market
Table 33. Key Manufacturers Human Gene Therapy Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Human Gene Therapy Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Human Gene Therapy Sales by Region (2018-2024) & (K Units)
Table 37. Global Human Gene Therapy Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Human Gene Therapy Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Human Gene Therapy Sales Market Share in Value by Region (2018-2024)
Table 40. Global Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Human Gene Therapy Sales by Region (2024-2029) & (K Units)
Table 42. Global Human Gene Therapy Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Human Gene Therapy Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Human Gene Therapy Sales Market Share in Value by Region (2024-2029)
Table 45. Global Human Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Human Gene Therapy Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Human Gene Therapy Sales by Application (2018-2024) & (K Units)
Table 48. Global Human Gene Therapy Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Human Gene Therapy Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Human Gene Therapy Sales Market Share in Value by Application (2018-2024)
Table 51. Global Human Gene Therapy Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Human Gene Therapy Sales by Application (2024-2029) & (K Units)
Table 53. Global Human Gene Therapy Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Human Gene Therapy Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Human Gene Therapy Sales Market Share in Value by Application (2024-2029)
Table 56. Global Human Gene Therapy Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Human Gene Therapy Sales by Application (2018-2024) (K Units)
Table 58. North America Human Gene Therapy Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Human Gene Therapy Sales by Application (2018-2024) (K Units)
Table 60. Europe Human Gene Therapy Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Human Gene Therapy Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Human Gene Therapy Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Human Gene Therapy Sales by Application (2018-2024) (K Units)
Table 64. Latin America Human Gene Therapy Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Human Gene Therapy Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Human Gene Therapy Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 68. North America Human Gene Therapy Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Human Gene Therapy Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Human Gene Therapy Sales Market Share in Value by Country (2018-2024)
Table 71. North America Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 72. North America Human Gene Therapy Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Human Gene Therapy Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Human Gene Therapy Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 76. Europe Human Gene Therapy Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Human Gene Therapy Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Human Gene Therapy Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 80. Europe Human Gene Therapy Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Human Gene Therapy Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Human Gene Therapy Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Human Gene Therapy Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Human Gene Therapy Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Human Gene Therapy Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Human Gene Therapy Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Human Gene Therapy Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Human Gene Therapy Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Human Gene Therapy Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Human Gene Therapy Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Human Gene Therapy Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Human Gene Therapy Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Human Gene Therapy Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Human Gene Therapy Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Human Gene Therapy Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Human Gene Therapy Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Human Gene Therapy Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Human Gene Therapy Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Human Gene Therapy Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Human Gene Therapy Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Human Gene Therapy Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Human Gene Therapy Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Human Gene Therapy Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Human Gene Therapy Sales Market Share in Value by Country (2024-2029)
Table 107. Biogen Company Information
Table 108. Biogen Introduction and Business Overview
Table 109. Biogen Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Biogen Human Gene Therapy Product
Table 111. Biogen Recent Development
Table 112. Sarepta Therapeutics Company Information
Table 113. Sarepta Therapeutics Introduction and Business Overview
Table 114. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sarepta Therapeutics Human Gene Therapy Product
Table 116. Sarepta Therapeutics Recent Development
Table 117. Gilead Sciences Company Information
Table 118. Gilead Sciences Introduction and Business Overview
Table 119. Gilead Sciences Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Gilead Sciences Human Gene Therapy Product
Table 121. Gilead Sciences Recent Development
Table 122. Amgen Company Information
Table 123. Amgen Introduction and Business Overview
Table 124. Amgen Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Amgen Human Gene Therapy Product
Table 126. Amgen Recent Development
Table 127. Novartis Company Information
Table 128. Novartis Introduction and Business Overview
Table 129. Novartis Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Novartis Human Gene Therapy Product
Table 131. Novartis Recent Development
Table 132. Orchard Therapeutics Company Information
Table 133. Orchard Therapeutics Introduction and Business Overview
Table 134. Orchard Therapeutics Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Orchard Therapeutics Human Gene Therapy Product
Table 136. Orchard Therapeutics Recent Development
Table 137. Spark Therapeutics Company Information
Table 138. Spark Therapeutics Introduction and Business Overview
Table 139. Spark Therapeutics Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Spark Therapeutics Human Gene Therapy Product
Table 141. Spark Therapeutics Recent Development
Table 142. Agc Biologics Company Information
Table 143. Agc Biologics Introduction and Business Overview
Table 144. Agc Biologics Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Agc Biologics Human Gene Therapy Product
Table 146. Agc Biologics Recent Development
Table 147. Anges Company Information
Table 148. Anges Introduction and Business Overview
Table 149. Anges Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Anges Human Gene Therapy Product
Table 151. Anges Recent Development
Table 152. Bluebird Bio Company Information
Table 153. Bluebird Bio Introduction and Business Overview
Table 154. Bluebird Bio Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Bluebird Bio Human Gene Therapy Product
Table 156. Bluebird Bio Recent Development
Table 157. Jazz Pharmaceuticals Company Information
Table 158. Jazz Pharmaceuticals Introduction and Business Overview
Table 159. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Jazz Pharmaceuticals Human Gene Therapy Product
Table 161. Jazz Pharmaceuticals Recent Development
Table 162. Dynavax Technologies Company Information
Table 163. Dynavax Technologies Introduction and Business Overview
Table 164. Dynavax Technologies Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Dynavax Technologies Human Gene Therapy Product
Table 166. Dynavax Technologies Recent Development
Table 167. Human Stem Cells Institute Company Information
Table 168. Human Stem Cells Institute Introduction and Business Overview
Table 169. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Human Stem Cells Institute Human Gene Therapy Product
Table 171. Human Stem Cells Institute Recent Development
Table 172. Sibiono Genetech Company Information
Table 173. Sibiono Genetech Introduction and Business Overview
Table 174. Sibiono Genetech Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Sibiono Genetech Human Gene Therapy Product
Table 176. Sibiono Genetech Recent Development
Table 177. Shanghai Sunway Biotech Company Information
Table 178. Shanghai Sunway Biotech Introduction and Business Overview
Table 179. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Shanghai Sunway Biotech Human Gene Therapy Product
Table 181. Shanghai Sunway Biotech Recent Development
Table 182. Uniqure N.V. Company Information
Table 183. Uniqure N.V. Introduction and Business Overview
Table 184. Uniqure N.V. Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Uniqure N.V. Human Gene Therapy Product
Table 186. Uniqure N.V. Recent Development
Table 187. Gensight Biologics S.A. Company Information
Table 188. Gensight Biologics S.A. Introduction and Business Overview
Table 189. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Gensight Biologics S.A. Human Gene Therapy Product
Table 191. Gensight Biologics S.A. Recent Development
Table 192. Celgene Corporation Company Information
Table 193. Celgene Corporation Introduction and Business Overview
Table 194. Celgene Corporation Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 195. Celgene Corporation Human Gene Therapy Product
Table 196. Celgene Corporation Recent Development
Table 197. Cellectis Company Information
Table 198. Cellectis Introduction and Business Overview
Table 199. Cellectis Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 200. Cellectis Human Gene Therapy Product
Table 201. Cellectis Recent Development
Table 202. Sangamo Therapeutics Company Information
Table 203. Sangamo Therapeutics Introduction and Business Overview
Table 204. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 205. Sangamo Therapeutics Human Gene Therapy Product
Table 206. Sangamo Therapeutics Recent Development
Table 207. Mustang Bio Company Information
Table 208. Mustang Bio Introduction and Business Overview
Table 209. Mustang Bio Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 210. Mustang Bio Human Gene Therapy Product
Table 211. Mustang Bio Recent Development
Table 212. AGTC Company Information
Table 213. AGTC Introduction and Business Overview
Table 214. AGTC Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 215. AGTC Human Gene Therapy Product
Table 216. AGTC Recent Development
Table 217. Poseida Therapeutics Company Information
Table 218. Poseida Therapeutics Introduction and Business Overview
Table 219. Poseida Therapeutics Human Gene Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 220. Poseida Therapeutics Human Gene Therapy Product
Table 221. Poseida Therapeutics Recent Development
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Human Gene Therapy Market Trends
Table 225. Human Gene Therapy Market Drivers
Table 226. Human Gene Therapy Market Challenges
Table 227. Human Gene Therapy Market Restraints
Table 228. Human Gene Therapy Distributors List
Table 229. Human Gene Therapy Downstream Customers
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Gene Therapy Product Picture
Figure 2. Global Human Gene Therapy Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Gene Therapy Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Human Gene Therapy Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Non-viral Vectors
Figure 6. Global Non-viral Vectors Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Viral Vectors
Figure 8. Global Viral Vectors Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Human Gene Therapy Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Human Gene Therapy Sales Market Share by Type in 2022 & 2029
Figure 11. North America Human Gene Therapy Sales Market Share in Volume by Type in 2022
Figure 12. North America Human Gene Therapy Sales Market Share in Value by Type in 2022
Figure 13. Europe Human Gene Therapy Sales Market Share in Volume by Type in 2022
Figure 14. Europe Human Gene Therapy Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Human Gene Therapy Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Human Gene Therapy Sales Market Share in Value by Type in 2022
Figure 17. Latin America Human Gene Therapy Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Human Gene Therapy Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Human Gene Therapy Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Human Gene Therapy Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Gene Therapy Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Gene Therapy Revenue in 2022
Figure 23. Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Neurological Diseases
Figure 25. Global Neurological Diseases Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Cancer
Figure 27. Global Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of DMD (Duchenne Muscular Dystrophy)
Figure 29. Global DMD (Duchenne Muscular Dystrophy) Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Hepatological Diseases
Figure 31. Global Hepatological Diseases Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Human Gene Therapy Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Human Gene Therapy Sales Market Share by Application in 2022 & 2029
Figure 36. North America Human Gene Therapy Sales Market Share in Volume by Application in 2022
Figure 37. North America Human Gene Therapy Sales Market Share in Value by Application in 2022
Figure 38. Europe Human Gene Therapy Sales Market Share in Volume by Application in 2022
Figure 39. Europe Human Gene Therapy Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Human Gene Therapy Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Human Gene Therapy Sales Market Share in Value by Application in 2022
Figure 42. Latin America Human Gene Therapy Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Human Gene Therapy Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Human Gene Therapy Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Human Gene Therapy Manufacturing Cost Structure
Figure 47. Human Gene Therapy Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed